This publication reports on measles based on surveillance data from 1 January 2016 to 30 June 2017 and epidemic intelligence up to the first week of September 2017. For rubella, the report covers surveillance data from 1 July 2016 to 30 June 2017.
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations.
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations.
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 49 deaths due to measles have been reported in the EU,
Measles and rubella are targeted for elimination in Europe by 2015. ECDC closely monitors progress towards interruption of endemic transmission of both diseases through enhanced surveillance and epidemic intelligence.
Data from the latest European monthly measles monitoring report (EMMO) show the overall number of cases reported in first quarter of 2012 is considerably lower compared to the same period last year. In 2011, the reported cases of measles was 11 386 while in January–March 2012, 2 283 measles cases were reported to ECDC.
8 230 cases of measles were reported in EU/EEA countries in 2012, and rubella cases numbered 27 276. Whilst the number of measles cases is significantly lower than 2011 and 2010 it still continues to exceed the measles elimination target rate of less than one case per million people. The number of rubella cases, on the other hand, has jumped up from the 3 442 cases in the previous year.
The ECDC measles and rubella monitoring report presents regular updates on measles and rubella transmission in Europe based on reporting from EU and EEA/EFTA countries and ECDC epidemic intelligence activities.
Measles and rubella are targeted for elimination in Europe by 2015. ECDC closely monitors progress towards interruption of endemic transmission of both diseases through enhanced surveillance and epidemic intelligence.
